A methylmalonic acid test measures how much methylmalonic acid is in your blood or urine. MMA rises when cells do not have enough usable vitamin B12 to run a specific energy pathway. For that reason, MMA is one of the most helpful follow-up tests when a vitamin B12 result is borderline, symptoms suggest B12 deficiency, or a person has risk factors for poor B12 absorption.
A high MMA result most often points toward functional vitamin B12 deficiency, but it is not specific by itself. Kidney disease, older age, dehydration, and rare inherited metabolic disorders can also raise MMA. The result is most useful when it is interpreted with vitamin B12, symptoms, kidney function, a complete blood count, and sometimes homocysteine or holotranscobalamin.
MMA testing can help catch B12 deficiency before anemia appears, which matters because nerve symptoms can occur even when hemoglobin and MCV look normal.
- The MMA test measures functional vitamin B12 activity, not just the amount of B12 circulating in the blood.
- A common serum MMA reference range is up to 0.40 µmol/L, but each lab’s range should be used first.
- High MMA usually suggests vitamin B12 deficiency, especially when B12 is low or borderline and kidney function is normal.
- Kidney impairment can falsely raise MMA, so creatinine and eGFR help prevent misinterpretation.
- Low MMA is usually not a medical problem and often means B12-dependent metabolism is working normally.
- Treatment should not be delayed when serious neurologic symptoms or megaloblastic anemia are present.
Table of Contents
- What the MMA Test Measures
- MMA Normal Range and Result Patterns
- High MMA and Vitamin B12 Deficiency
- Other Causes of High MMA
- MMA vs. B12, Homocysteine, and Related Tests
- Preparation and What Happens During the Test
- What to Do After Abnormal MMA Results
- Common MMA Result Scenarios
What the MMA Test Measures
Methylmalonic acid is a small organic acid made during the breakdown of certain amino acids and fatty acids. Your body normally keeps MMA low because vitamin B12 helps convert a related compound, methylmalonyl-CoA, into succinyl-CoA, which then enters energy metabolism.
When cells do not have enough usable vitamin B12, that conversion slows down. MMA builds up in blood and can spill into urine. This is why MMA is often called a “functional” B12 marker. It reflects whether B12-dependent chemistry is working inside cells, not just whether total B12 is present in the bloodstream.
That distinction matters because a standard vitamin B12 blood test can sometimes look low-normal, normal, or even high while a person still has poor cellular B12 activity. This can happen with early deficiency, recent supplementation, certain binding-protein changes, kidney or liver disease, autoimmune conditions, or assay interference.
Doctors most often order MMA when:
- Vitamin B12 is borderline.
- Symptoms suggest B12 deficiency.
- A person has nerve symptoms, cognitive changes, or unexplained fatigue.
- A complete blood count shows macrocytosis or anemia.
- There are risk factors for poor B12 absorption.
- Nitrous oxide exposure is suspected.
- A baby’s newborn screen suggests methylmalonic acidemia.
For adults, the most common use is evaluating possible B12 deficiency. In newborn screening and pediatrics, MMA can also help detect rare inherited disorders that affect methylmalonic acid metabolism. Those conditions are different from ordinary nutritional B12 deficiency and need specialist care.
MMA can be measured in serum, plasma, random urine, or 24-hour urine, depending on the lab and clinical question. Blood MMA is most common for adult B12 evaluation. Urine MMA is more common in some metabolic workups and may become more useful in older adults as testing methods improve.
MMA Normal Range and Result Patterns
A normal MMA result usually means vitamin B12-dependent metabolism is working well at the time of testing. A high result means MMA is accumulating, most often because of B12 deficiency or reduced kidney clearance.
Reference ranges vary by lab, specimen type, testing method, age, and units. A commonly used adult serum reference value is 0.40 µmol/L or lower. This is the same as 0.40 nmol/mL or 400 nmol/L. Some laboratories use lower upper limits, especially in younger adults, while older adults may have slightly higher expected values.
Always compare your number with the reference interval printed on your own report.
| Result pattern | Common meaning | Usual next step |
|---|---|---|
| Within the lab range | B12-dependent metabolism is usually adequate | Review symptoms and other labs if suspicion remains high |
| Mildly high | Possible early or functional B12 deficiency; kidney function can also contribute | Check B12, creatinine/eGFR, CBC, and risk factors |
| Clearly high | More consistent with B12 deficiency if kidney function is normal | Identify the cause and start appropriate B12 replacement when indicated |
| Very high | Severe B12 deficiency, marked kidney impairment, or rare metabolic disease may be present | Prompt clinical review, especially with neurologic symptoms or anemia |
| Low | Usually not clinically important | No action unless other results are abnormal |
A single MMA value should not be read as a stand-alone diagnosis. A result just above the upper limit can have a different meaning in a healthy 25-year-old than in an 85-year-old with reduced eGFR. The pattern across tests is more useful than the isolated number.
For example, a high MMA with low B12, high MCV, and tingling in the feet strongly supports B12 deficiency. A high MMA with normal B12 but low eGFR may reflect reduced kidney clearance rather than poor B12 status. A normal MMA with severe neurologic symptoms does not completely rule out B12-related disease, especially if testing happened after supplements or injections.
Urine MMA results use different units. Some reports express MMA relative to creatinine to adjust for urine concentration. For random urine, a lab may report a ratio such as mmol/mol creatinine or µmol/mmol creatinine. Urine and blood results should not be compared directly.
High MMA and Vitamin B12 Deficiency
High MMA is most useful because it can reveal B12 deficiency at the cellular level. Vitamin B12 is needed for red blood cell production, nerve protection, DNA synthesis, and energy metabolism. When B12 is low enough to disrupt those processes, MMA often rises before classic anemia appears.
B12 deficiency can cause a wide range of symptoms, including:
- Fatigue, weakness, or shortness of breath
- Pale skin, dizziness, or palpitations from anemia
- Tingling, burning, or numbness in the hands or feet
- Poor balance, unsteady walking, or falls
- Memory problems, confusion, low mood, or irritability
- Sore tongue, mouth ulcers, appetite loss, or diarrhea
- Vision changes in more severe cases
A person can have nerve symptoms without anemia. This is one reason MMA can be valuable. The absence of a low hemoglobin result does not always make B12 deficiency harmless or unlikely.
Common causes of B12 deficiency include low intake, poor absorption, medication effects, and stomach or intestinal disorders. Low intake is more likely in people who eat little or no animal-source food and do not use reliable fortified foods or supplements. Poor absorption is common in autoimmune gastritis, pernicious anemia, gastric bypass surgery, ileal disease or resection, Crohn’s disease, celiac disease, chronic atrophic gastritis, and some older adults.
Medication history also matters. Long-term metformin can lower B12 status in some people. Long-term acid-suppressing medicines, such as proton pump inhibitors or H2 blockers, may contribute by reducing release of B12 from food proteins. Nitrous oxide can inactivate B12 and may cause neurologic symptoms even when the blood B12 level is not dramatically low.
A related article on low vitamin B12 results can help clarify how low serum B12, symptoms, and follow-up markers fit together.
A high MMA result is especially persuasive when several findings point in the same direction:
- Low or borderline serum B12
- Low active B12, also called holotranscobalamin
- High homocysteine
- Macrocytosis, meaning enlarged red blood cells
- Anemia, low white cells, or low platelets in severe deficiency
- Risk factors for malabsorption
- Neurologic symptoms typical of B12 deficiency
- Improvement after appropriate B12 treatment
Treatment decisions should also consider severity. When someone has suspected B12 deficiency with megaloblastic anemia or neurologic symptoms such as gait problems, progressive numbness, weakness, or signs of spinal cord involvement, clinicians often start treatment quickly after drawing diagnostic blood samples. Waiting for every result can risk preventable nerve injury.
Other Causes of High MMA
High MMA does not always mean B12 deficiency. The result becomes more accurate when the clinician checks for factors that raise MMA for other reasons.
Kidney function is the most common confounder. MMA is cleared partly through the kidneys. When kidney filtration falls, MMA can rise even if B12 status is adequate. Creatinine and estimated glomerular filtration rate are therefore important companions to MMA testing. If kidney function is reduced, a kidney function blood test panel helps put the MMA result in context.
Age also affects MMA interpretation. Older adults tend to have higher MMA on average, partly because kidney function declines with age and partly because B12 absorption problems become more common. This does not mean high MMA should be ignored in older people. It means the result should be interpreted with symptoms, eGFR, diet, medications, and other B12 markers.
Other possible causes or contributors include:
- Dehydration: reduced fluid volume can concentrate blood markers and may worsen kidney-related MMA elevation.
- Methylmalonic acidemia: rare inherited enzyme or B12-processing disorders can cause very high MMA, often detected in infancy or childhood.
- Recent serious illness: acute illness can complicate interpretation through kidney stress, poor intake, inflammation, or medication changes.
- Small intestinal bacterial overgrowth: some gut conditions may affect B12 handling, though this is not the most common explanation.
- Laboratory and specimen issues: delayed processing, different methods, or specimen type can affect comparability between results.
A mild MMA elevation with normal B12 markers and reduced eGFR may not call for the same response as a high MMA with neurologic symptoms and a long history of malabsorption. The clinical picture decides how urgent the result is.
Low MMA is rarely a concern. Unlike low sodium, low calcium, or low iron stores, low MMA is not usually treated as a deficiency marker. It typically suggests that methylmalonic acid is not accumulating. Very low results do not usually require follow-up unless the report includes another abnormality.
MMA vs. B12, Homocysteine, and Related Tests
MMA answers one question: “Is the B12-dependent methylmalonyl-CoA pathway struggling?” Other tests answer different questions. Combining them often gives a clearer answer than repeating the same test.
Serum vitamin B12
Serum B12 measures total circulating B12, including B12 bound to proteins that may not be available to cells. It is widely available and useful as a first test, but it has a gray zone. Low values support deficiency. Borderline values often need MMA or another marker. Normal values reduce the chance of deficiency but do not fully exclude it when symptoms and risk factors are strong.
Holotranscobalamin
Holotranscobalamin measures the active fraction of B12 bound to transcobalamin. It may fall earlier than total B12 in some people. A holotranscobalamin test can be helpful when standard B12 is difficult to interpret, though availability varies.
Homocysteine
Homocysteine often rises in B12 deficiency, but it can also rise with folate deficiency, vitamin B6 deficiency, vitamin B2 deficiency, kidney disease, hypothyroidism, smoking, and some medications. A homocysteine blood test is less specific for B12 than MMA, but it can add useful context when interpreted carefully.
Folate
Folate deficiency can cause macrocytic anemia and high homocysteine, but it usually does not raise MMA. That difference helps separate folate-related anemia from B12-related MMA elevation. If macrocytosis is present, a folate blood test may be checked along with B12 markers.
Complete blood count and MCV
A complete blood count shows whether anemia, low white blood cells, low platelets, or enlarged red blood cells are present. B12 deficiency classically causes macrocytic anemia, but early or neurologic B12 deficiency can occur before CBC changes. A complete blood count test and an elevated MCV result are useful clues, not final proof.
| Test | What it shows | Main limitation |
|---|---|---|
| MMA | Functional B12 activity in one metabolic pathway | Can rise with kidney impairment and age |
| Total B12 | Amount of B12 circulating in blood | Can miss functional deficiency or be distorted by supplements and binding proteins |
| Holotranscobalamin | Active B12 available for cellular uptake | Not available everywhere; cutoffs vary |
| Homocysteine | Methylation pathway affected by B vitamins | Less specific because folate, B6, B2, kidney function, and thyroid status can affect it |
| CBC and MCV | Blood cell effects of deficiency | Can be normal in early or neurologic B12 deficiency |
MMA is often strongest when the question is whether a borderline B12 result is truly causing a metabolic problem. It is less useful as a broad screening test in everyone because it costs more than total B12 and can be harder to interpret in kidney disease.
Preparation and What Happens During the Test
MMA testing usually needs little preparation. For a blood MMA test, a healthcare professional draws blood from a vein in the arm. The draw usually takes less than five minutes. For urine MMA, the lab may request a random urine sample or a 24-hour collection. Some specialized urine tests use a creatinine-adjusted ratio.
Ask the ordering clinician or lab whether fasting is needed. Many MMA blood tests do not require fasting, but some clinicians prefer a fasting morning sample when results will be compared with other metabolic markers. Follow the lab instructions on the order.
Before the test, tell your clinician about:
- Vitamin B12 tablets, injections, sprays, or multivitamins
- Recent high-dose B-complex supplements
- Metformin, proton pump inhibitors, H2 blockers, or antiseizure medicines
- Kidney disease or abnormal creatinine/eGFR
- Nitrous oxide use, including recreational use
- Pregnancy or breastfeeding
- Recent antibiotics, serious illness, dehydration, or hospitalization
When possible, diagnostic blood samples should be taken before starting B12 treatment. Supplements or injections can change serum B12 quickly and may lower MMA over time, making the original problem harder to document. This does not mean treatment should wait in high-risk situations. If symptoms are severe, clinicians may draw blood immediately and start B12 replacement the same day.
For a 24-hour urine collection, accuracy depends on collecting every urine sample during the full collection period. Missing one sample can make the result unreliable. Keep the container stored as instructed, and write down the start and stop times if the lab asks.
MMA results are not always available the same day because many labs use specialized mass spectrometry methods. Turnaround may range from a few days to longer, depending on whether the sample is sent to a reference lab.
What to Do After Abnormal MMA Results
A high MMA result should lead to a focused review rather than panic. The first step is to confirm whether the pattern fits B12 deficiency, kidney-related elevation, or another cause.
A practical follow-up often includes:
- Review symptoms, especially nerve, balance, mood, memory, and anemia symptoms.
- Compare MMA with total B12 and the lab’s reference range.
- Check creatinine and eGFR to assess kidney clearance.
- Review CBC, MCV, and sometimes a blood smear.
- Check folate and homocysteine if macrocytosis or mixed deficiency is possible.
- Look for causes: diet, autoimmune gastritis, gastrointestinal disease, surgery, medications, and nitrous oxide.
- Decide whether oral or injected B12 is appropriate.
- Reassess symptoms after treatment.
B12 treatment depends on the cause and severity. High-dose oral B12, often around 1,000 mcg daily, can work for many people, including some with impaired absorption because a small amount can be absorbed passively. Intramuscular B12 is commonly preferred when malabsorption is severe, symptoms are significant, adherence is uncertain, or rapid correction is needed. People with autoimmune gastritis, total gastrectomy, or complete terminal ileal resection often need long-term or lifelong replacement.
Symptoms may improve at different speeds. Fatigue and blood count changes may begin improving within weeks. Neurologic symptoms often take longer and may improve over months. Some long-standing nerve damage may not fully reverse, which is why early recognition matters.
Repeat MMA testing is not always necessary after treatment. It can be useful when the diagnosis was uncertain, when oral absorption is in question, or when symptoms do not improve as expected. Clinicians often follow symptoms, CBC, B12, and sometimes MMA or homocysteine depending on the original pattern.
Seek prompt medical care if high MMA occurs with progressive numbness, weakness, trouble walking, falls, confusion, severe anemia symptoms, chest pain, fainting, or shortness of breath at rest. These symptoms need direct clinical assessment, not just supplement adjustment.
Common MMA Result Scenarios
High MMA with low vitamin B12
This pattern strongly supports B12 deficiency, especially if kidney function is normal. The next step is to identify the cause and treat. The cause matters because dietary deficiency may be corrected differently from autoimmune gastritis, Crohn’s disease, gastric bypass, or medication-related deficiency.
High MMA with borderline vitamin B12
This is one of the most common reasons MMA is ordered. A borderline B12 result may not show whether cells have enough B12. If MMA is high and symptoms or risk factors fit, clinicians often treat as B12 deficiency while checking for causes.
High MMA with normal vitamin B12
This pattern needs careful interpretation. It can reflect functional B12 deficiency, recent supplements, kidney impairment, older age, or assay-related issues. Holotranscobalamin, homocysteine, kidney function, medication history, and symptoms can help clarify the result. If the person has neurologic symptoms or nitrous oxide exposure, normal serum B12 should not be used to dismiss the concern.
Normal MMA with low vitamin B12
This may mean B12 is low but not yet causing measurable functional impairment. It can also occur when B12 is mildly low due to binding-protein differences rather than true deficiency. Symptoms, diet, risk factors, and repeat testing guide the next step. Some clinicians still treat low B12 in high-risk patients because B12 replacement is generally safe and deficiency can be harmful.
High MMA with high homocysteine
This combination supports B12 deficiency more strongly than either marker alone, although kidney disease can raise both. If homocysteine is high but MMA is normal, folate, B6, B2, kidney function, thyroid status, and lifestyle factors become more important to review.
High MMA after B12 treatment
Persistent high MMA after treatment may mean the dose is too low, oral absorption is poor, adherence is inconsistent, treatment has not had enough time to work, kidney function is reduced, or the original elevation was not mainly from B12 deficiency. The response should be judged with symptoms and other labs, not MMA alone.
Very high MMA in a baby or child
Very high MMA in infants or children can suggest methylmalonic acidemia or another inherited metabolic condition, especially when there are feeding problems, vomiting, poor growth, developmental delay, lethargy, acidosis, or abnormal newborn screening. This situation requires urgent specialist evaluation.
Normal MMA but ongoing nerve symptoms
Normal MMA lowers the chance that B12 deficiency is driving symptoms, but it does not replace a clinical exam. Neuropathy, balance problems, or cognitive changes can come from diabetes, thyroid disease, alcohol-related nerve injury, copper deficiency, spinal disease, medications, autoimmune disease, infections, and many other causes. Persistent symptoms deserve follow-up even when MMA is normal.
References
- Vitamin B12 deficiency in over 16s: diagnosis and management 2024 (Guideline)
- Diagnosis, Treatment and Long-Term Management of Vitamin B12 Deficiency in Adults: A Delphi Expert Consensus 2024 (Consensus)
- Vitamin B12-Related Biomarkers 2024 (Review)
- Methylmalonic Acid (MMA) Test 2024 (Official Patient Information)
- Vitamin B12 – Health Professional Fact Sheet 2025 (Official Fact Sheet)
- Examining the Clinical Usefulness of Urine Methylmalonic Acid for Diagnosis of Vitamin B-12 Deficiency in Older Adults: A Pilot Study 2026 (Pilot Study)
Disclaimer
MMA results should be interpreted by a qualified healthcare professional together with symptoms, kidney function, vitamin B12 status, blood count results, medications, and medical history. Do not delay urgent care for progressive numbness, weakness, trouble walking, confusion, severe anemia symptoms, chest pain, or shortness of breath. Vitamin B12 treatment is often safe, but the cause of deficiency still matters because some people need long-term replacement or further testing.
